SENATE BILL REPORT
SB 6623
As of February 01, 2006
Title: An act relating to business and occupation tax exemption for chemotherapy and anticancer drugs dispensed pursuant to prescription.
Brief Description: Creating a business and occupation tax exemption for chemotherapy and anticancer drugs dispensed pursuant to prescription.
Sponsors: Senators Prentice, Brandland, Parlette, Schoesler, Thibaudeau, Keiser, Oke, McAuliffe, Roach, Rasmussen and Shin.
Brief History:
Committee Activity: Ways & Means: 2/2/06.
SENATE COMMITTEE ON WAYS & MEANS
Staff: Dean Carlson (786-7305)
Background: The business and occupation (B&O) tax is imposed on the gross receipts from
all business activities conducted within the state. Revenues are deposited in the State General
Fund. A business may have more than one B&O tax rate, depending on the types of activities
conducted. There are a number of different B&O tax rates. The main rates are 0.471 percent for
retailing; 0.484 percent for manufacturing, wholesaling, and extracting; and 1.5 percent for
professional and personal services, including physician services.
Public hospitals, nonprofit hospitals, and nonprofit community health centers are allowed a
deduction from B&O tax on amounts received as compensation for health care services covered
under the federal Medicare program, as well as from the Basic Health Plan and other medical
assistance programs funded by the state of Washington. Amounts billed for these programs by
other clinics or physicians are not exempt from tax.
Summary of Bill: An exemption from B&O tax is provided for amounts derived from sales of prescription chemotherapy and anticancer drugs for infusion or injection for human use, if the drugs are sold for an amount not exceeding the rate at or below which the federal government reimburses under Medicare.
Appropriation: None.
Fiscal Note: Available.
Committee/Commission/Task Force Created: No.
Effective Date: Ninety days after adjournment of session in which bill is passed.